CMS drops AMP Christmas surprise

January 2007
Drug Topics;1/8/2007, Vol. 151 Issue 1, p8
Trade Publication
The article examines the new rules issued by the Centers for Medicare and Medicaid Services (CMS)regarding the Medicaid reimbursement in the U.S. Issued on December 22, 2006, the new rules aims to cut more that $8 billion in Medicaid prescription generic drugs over a five year period. CMS hopes to reduce reimburse generics by as much as $800 million for 2007 wherein the new rules establish reimbursement as 250 percent of the average manufacturers price. Pharmacy leaders expresssed their reservations regarding several points of the new rules.


Related Articles

  • Medicaid Muddle. Toth, Wendy; Alaimo, Dan // SN: Supermarket News;8/13/2007, Vol. 55 Issue 33, p25 

    The article focuses on the Medicaid generic drug reimbursement formula released by the U.S. Centers for Medicare & Medicaid Services. The payment method will use the Average Manufacturer Price of drugs to establish a reimbursement formula. The old calculation used the Average Wholesaler Price....

  • Pharmacy groups on warpath over AMP. Paul, Reid // Drug Topics;7/23/2007, Vol. 151 Issue 14, p10 

    The article reports that the U.S. Centers for Medicare & Medicaid Services' (CMS) release of the final version of its average manufacturer price (AMP) rule has received universal disapproval from pharmacy organizations. The rule implements one of the elements of the Deficit Reduction Act of...

  • States divided over Medicaid AMP rule. Paul, Reid // Drug Topics;6/4/2007, Vol. 151 Issue 11, p24 

    The article reports that several U.S. states have already started to take action to prevent the impact of Centers for Medicare and Medicaid Services' final rule for implementation of average manufacturer price (AMP) for Medicaid reimbursement on generic drugs which is expected to take effect on...

  • Pharmacists livid and desperate over AMP rule. Paul, Reid // Drug Topics;8/6/2007, Vol. 151 Issue 15, p18 

    The article reports on the implementation of the average manufacturer price (AMP) reimbursement rule for Medicaid generic drugs by the Centers for Medicare & Medicaid Services (CMS). The rule states that drug prices in the Medicaid program will be reimbursed at two hundred fifty percent of the...

  • Industry looks to Congress, states for Mediôaid relief.  // Drug Store News;8/13/2007, Vol. 29 Issue 10, p56 

    The article reports that the pharmaceutical industry has turned for relief to Congress after failing to stop the new Medicaid payment guidelines for generic drugs by the Centers for Medicare & Medicaid Services (CMS) in the U.S. Pharmacy leaders raised concerns over the impact of the rules on...

  • Medicaid Drug-Pricing Policy Reworks AM. Wechsler, Jill // Pharmaceutical Executive;Sep2007, Vol. 27 Issue 9, p20 

    The article discusses on the revised regulation by the Centers for Medicare and Medicaid Services (CMS) for calculating the average manufacturer price (AMP) for medicine purchased by Medicaid programs in the U.S. According to reports, by setting lower and realistic reimbursement rates for...

  • Pharmacy to CMS: Medicaid rule is recipe for disaster. Paul, Reid // Drug Topics;1/22/2007, Vol. 151 Issue 2, p34 

    The article focuses on the proposed rule of the Centers for Medicare & Medicaid Services under the provisions of the Deficit Reduction Act of 2005 (DRA) concerning the five-year period Medicaid generic drug reimbursement. The DRA covers the modification of the formula for calculating federal...

  • Proposed Part D rule changes could be bane to brand drugmakers. Serebrov, Mari // BioWorld Today;1/8/2014, Vol. 25 Issue 5, p1 

    The article discusses the U.S. Centers for Medicare & Medicaid Services' proposal of Part D rule change that would tip the formulary scale in favor of generics and biosimilars which is seen as a bane to pharmaceutical firms. The changes aims to remove the protection antidepressants and...

  • CMS Releases Updated, Aggressive 5010 Timeline.  // Medicare Compliance & Reimbursement;1/7/2012, Vol. 38 Issue 1, pp7 

    The article offers updates related to Medicare and Medicaid in the U.S. It notes that the Center for Medicare and Medicaid Services (CMS) will not initiate enforcement action on some of practices in the 5010 compliance until March 31, 2012 while the Congress plans to take Medicare pay cuts...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics